Literature DB >> 20142103

Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation.

Jun Guo1, Minlin Liu, Dehong Yang, Mary L Bouxsein, Hiroaki Saito, R J Sells Galvin, Stuart A Kuhstoss, Clare C Thomas, Ernestina Schipani, Roland Baron, F Richard Bringhurst, Henry M Kronenberg.   

Abstract

Parathyroid hormone (PTH) suppresses Dickkopf 1 (Dkk1) expression in osteoblasts. To determine whether this suppression is essential for PTH-mediated Wnt signaling and bone formation, we examined mice that overexpress Dkk1 in osteoblasts (Dkk1 mice). Dkk1 mice were osteopenic due to abnormal osteoblast and osteoclast activity. When fed a low-calcium diet, and in two other models of hyperparathyroidism, these mice failed to develop the peritrabecular stromal cell response ("osteitis fibrosis") and new bone formation seen in wild-type mice. Despite these effects of Dkk1 overexpression, PTH still activated Wnt signaling in Dkk1 mice and in osteoblastic cells cultured from these mice. In cultured MC3T3E1 preosteoblastic cells, PTH dramatically suppressed Dkk1 expression, induced PKA-mediated phosphorylation of beta-catenin, and significantly enhanced Lef1 expression. Our findings indicate that the full actions of PTH require intact Wnt signaling but that PTH can activate the Wnt pathway despite overexpression of Dkk1. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142103      PMCID: PMC2819982          DOI: 10.1016/j.cmet.2009.12.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  44 in total

1.  Control of the SOST bone enhancer by PTH using MEF2 transcription factors.

Authors:  Olivier Leupin; Ina Kramer; Nicole M Collette; Gabriela G Loots; François Natt; Michaela Kneissel; Hansjoerg Keller
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

2.  Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.

Authors:  Shmuel Yaccoby; Wen Ling; Fenghuang Zhan; Ronald Walker; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

3.  Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.

Authors:  D Yang; R Singh; P Divieti; J Guo; M L Bouxsein; F R Bringhurst
Journal:  Bone       Date:  2007-02-16       Impact factor: 4.398

4.  Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.

Authors:  Feng-Sheng Wang; Jih-Yang Ko; Chun-Liang Lin; Hsing-Long Wu; Huei-Jin Ke; Pei-Ju Tai
Journal:  Bone       Date:  2006-10-20       Impact factor: 4.398

5.  PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.

Authors:  Akira Suzuki; Keiichi Ozono; Takuo Kubota; Hiroki Kondou; Kanako Tachikawa; Toshimi Michigami
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

6.  Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.

Authors:  Zhengyu Liu; Joel F Habener
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

7.  Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3.

Authors:  Sebastien Taurin; Kyle Hogarth; Nathan Sandbo; Douglas M Yau; Nickolai O Dulin
Journal:  J Biol Chem       Date:  2007-05-19       Impact factor: 5.157

Review 8.  Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.

Authors:  Robert L Jilka
Journal:  Bone       Date:  2007-04-06       Impact factor: 4.398

9.  Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo.

Authors:  Heather E Fleming; Viktor Janzen; Cristina Lo Celso; Jun Guo; Kathleen M Leahy; Henry M Kronenberg; David T Scadden
Journal:  Cell Stem Cell       Date:  2008-03-06       Impact factor: 24.633

10.  Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF.

Authors:  Ken-ichi Fujita; Siegfried Janz
Journal:  Mol Cancer       Date:  2007-10-30       Impact factor: 27.401

View more
  91 in total

1.  Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.

Authors:  Maria-Grazia Ascenzi; Vivian P Liao; Brittany M Lee; Fabrizio Billi; Hua Zhou; Robert Lindsay; Felicia Cosman; Jeri Nieves; John P Bilezikian; David W Dempster
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

2.  BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b.

Authors:  Shoichiro Kokabu; Laura Gamer; Karen Cox; Jonathan Lowery; Kunikazu Tsuji; Regina Raz; Aris Economides; Takenobu Katagiri; Vicki Rosen
Journal:  Mol Endocrinol       Date:  2011-11-10

3.  Effects of age on parathyroid hormone signaling in human marrow stromal cells.

Authors:  Shuanhu Zhou; Ericka M Bueno; Sung Won Kim; Ilaria Amato; Longxiang Shen; Jochen Hahne; Ilan Bleiberg; Paul Morley; Julie Glowacki
Journal:  Aging Cell       Date:  2011-05-25       Impact factor: 9.304

Review 4.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 5.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

Review 6.  Signaling pathways affecting skeletal health.

Authors:  Pierre J Marie
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

7.  Association of serum Dkk-1 levels with β-catenin in patients with postmenopausal osteoporosis.

Authors:  Jun Tian; Xiao-Juan Xu; Lin Shen; Yan-Ping Yang; Rui Zhu; Bo Shuai; Xi-Wen Zhu; Cheng-Gang Li; Chen Ma; Lin Lv
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

Review 8.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

9.  Aortic carboxypeptidase-like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis.

Authors:  Toshiaki Teratani; Kengo Tomita; Takahiro Suzuki; Hirotaka Furuhashi; Rie Irie; Makoto Nishikawa; Junji Yamamoto; Toshifumi Hibi; Soichiro Miura; Tohru Minamino; Yuichi Oike; Ryota Hokari; Takanori Kanai
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

10.  Loss of Gsα early in the osteoblast lineage favors adipogenic differentiation of mesenchymal progenitors and committed osteoblast precursors.

Authors:  Partha Sinha; Piia Aarnisalo; Rhiannon Chubb; Noriaki Ono; Keertik Fulzele; Martin Selig; Hamid Saeed; Min Chen; Lee S Weinstein; Paola Divieti Pajevic; Henry M Kronenberg; Joy Y Wu
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.